A forum in Quebec, Canada, with 57 participants including patients, healthcare professionals, researchers, and policymakers, produced 16 recommendations for expanding access to psilocybin-assisted psychotherapy in palliative care. The recommendations address patient eligibility and equity, regulatory frameworks and respect for autonomy, logistical and organizational aspects, professional education and training, public awareness and information, and research. The report suggests these recommendations could guide similar efforts in other jurisdictions facing barriers to this therapy.
A decision aid for psilocybin-assisted therapy (PAT) was developed to help patients and healthcare professionals weigh risks and benefits when considering treatment for existential distress in serious illness. The booklet, created with a multidisciplinary steering committee following international standards, covers PAT education, treatment comparisons, and personal reflection. Feedback from five patients and five healthcare professionals guided refinements to improve clarity, balance, and usability. The final version met acceptability and usability criteria, offering balanced information to support shared decision-making in palliative care.